Advised Shanghai MicroPort Endovascular MedTech Co., Ltd. (stock code: 688016) (SH MicroPort) (a subsidiary of MicroPort Scientific Corporation listed on the Main Board of the Hong Kong Stock Exchange (stock code: 853)), as Hong Kong counsel, on the listing of Shanghai Stock Exchange STAR Market. SH MicroPort raised approximately RMB832 million.
SH MicroPort is principally engaged in the development and sale of medical instruments including peripheral vascular stents, aortic balloon dilation catheters, aortic stent grafts, and other related products.
Dealing in the shares of SH MicroPort on the Shanghai Stock Exchange STAR Market commenced on 22 July 2019.
Comments